Loading clinical trials...
Loading clinical trials...
MAGNesium and Digoxin Versus AMiodarone for Fast Atrial Fibrillation in the ICU (MAGNAM Trial)
Conditions
Interventions
Magnesium sulfate and then Digoxin
Amiodarone
Locations
5
Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
St Michael's Hospital
Toronto, Ontario, Canada
Mount Sinai Hospital
Toronto, Ontario, Canada
University Health Network - Toronto General Hospital
Toronto, Ontario, Canada
University Health Network - Toronto Western Hospital
Toronto, Ontario, Canada
Start Date
January 5, 2022
Primary Completion Date
October 31, 2025
Completion Date
April 30, 2026
Last Updated
April 25, 2024
NCT04528511
NCT03866148
NCT05780320
NCT04870424
NCT06793319
NCT06114719
Lead Sponsor
Sunnybrook Health Sciences Centre
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions